These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 20214889)
1. RANKL induces components of the extrinsic coagulation pathway in osteoclasts. Karlström E; Ek-Rylander B; Wendel M; Andersson G Biochem Biophys Res Commun; 2010 Apr; 394(3):593-9. PubMed ID: 20214889 [TBL] [Abstract][Full Text] [Related]
2. Localization and expression of prothrombin in rodent osteoclasts and long bones. Karlström E; Norgård M; Hultenby K; Somogyi-Ganss E; Sugars R; Andersson G; Wendel M Calcif Tissue Int; 2011 Mar; 88(3):179-88. PubMed ID: 21191574 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in the enhancement of osteoclast formation by enamel matrix derivative. Itoh N; Kasai H; Ariyoshi W; Harada E; Yokota M; Nishihara T J Periodontal Res; 2006 Aug; 41(4):273-9. PubMed ID: 16827720 [TBL] [Abstract][Full Text] [Related]
4. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL. Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111 [TBL] [Abstract][Full Text] [Related]
5. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2. Nishida S; Tsubaki M; Hoshino M; Namimatsu A; Uji H; Yoshioka S; Tanimori Y; Yanae M; Iwaki M; Irimajiri K Biochem Biophys Res Commun; 2005 Mar; 328(1):91-7. PubMed ID: 15670755 [TBL] [Abstract][Full Text] [Related]
6. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. Yu X; Huang Y; Collin-Osdoby P; Osdoby P J Bone Miner Res; 2003 Aug; 18(8):1404-18. PubMed ID: 12929930 [TBL] [Abstract][Full Text] [Related]
7. Osteoclast differentiation induced by synthetic octacalcium phosphate through receptor activator of NF-kappaB ligand expression in osteoblasts. Takami M; Mochizuki A; Yamada A; Tachi K; Zhao B; Miyamoto Y; Anada T; Honda Y; Inoue T; Nakamura M; Suzuki O; Kamijo R Tissue Eng Part A; 2009 Dec; 15(12):3991-4000. PubMed ID: 19594360 [TBL] [Abstract][Full Text] [Related]
8. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Takahashi N; Udagawa N; Suda T Biochem Biophys Res Commun; 1999 Mar; 256(3):449-55. PubMed ID: 10080918 [TBL] [Abstract][Full Text] [Related]
9. Factor X-dependent, thrombin-generating activities on a neuroblastoma cell and their disappearance upon differentiation. Inuyama H; Saito T; Takagi J; Saito Y J Cell Physiol; 1997 Dec; 173(3):406-14. PubMed ID: 9369954 [TBL] [Abstract][Full Text] [Related]
10. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644 [TBL] [Abstract][Full Text] [Related]
11. Dual modulation of osteoclast differentiation by lipopolysaccharide. Zou W; Bar-Shavit Z J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834 [TBL] [Abstract][Full Text] [Related]
12. Assembly and regulation of prothrombinase complex on B16F10 melanoma cells. Kirszberg C; Rumjanek VM; Monteiro RQ Thromb Res; 2005; 115(1-2):123-9. PubMed ID: 15567463 [TBL] [Abstract][Full Text] [Related]
13. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627 [TBL] [Abstract][Full Text] [Related]
15. Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation. Smith R; Ransjö M; Tatarczuch L; Song SJ; Pagel C; Morrison JR; Pike RN; Mackie EJ J Bone Miner Res; 2004 Mar; 19(3):507-16. PubMed ID: 15040840 [TBL] [Abstract][Full Text] [Related]
16. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles. Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342 [TBL] [Abstract][Full Text] [Related]
18. Regulation of prothrombinase activity by protein S. van 't Veer C; Butenas S; Golden NJ; Mann KG Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration. Voronov I; Heersche JN; Casper RF; Tenenbaum HC; Manolson MF Biochem Pharmacol; 2005 Jul; 70(2):300-7. PubMed ID: 15919055 [TBL] [Abstract][Full Text] [Related]
20. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex. Krishnaswamy S; Walker RK Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]